Bita Badiei
About Bita Badiei
Bita Badiei serves as the Executive Director of CMC Regulatory Affairs at Kite Pharma, bringing extensive experience in drug development, particularly in hemophilia, cell and gene therapies, and oncology. She has held various regulatory roles at notable companies, including Shire and Baxalta, and holds an MBA in Management and Leadership.
Current Role at Kite Pharma
Bita Badiei serves as the Executive Director of CMC Regulatory Affairs at Kite Pharma. She has held this position since 2017, contributing to the company's focus on cell and gene therapies. Her role involves overseeing regulatory compliance and ensuring that Kite Pharma's products meet the necessary standards for development and approval.
Previous Experience in Regulatory Affairs
Prior to her current position, Bita Badiei worked at several notable organizations in regulatory affairs. She was the Director of CMC Global Regulatory Affairs at Shire for 11 months in 2016-2017. Before that, she served as Associate Director of Global Regulatory Affairs at Baxalta from 2014 to 2016. Her extensive experience includes a 14-year tenure at Baxter International Inc. as Senior Manager of Global Regulatory Affairs.
Educational Background
Bita Badiei holds a Bachelor's degree in Chemistry from California State University, Northridge, where she studied from 2020 to 2022. Additionally, she earned a Master of Business Administration (MBA) in Management and Leadership from Fitchburg State University. Her educational background supports her extensive experience in the pharmaceutical industry.
Experience in Drug Development
Bita Badiei has extensive experience in drug development, particularly in areas such as hemophilia, cell and gene therapies, and oncology. Her career reflects a strong focus on regulatory affairs, where she has demonstrated a high aptitude for learning and the ability to work effectively in a matrix environment.
Career Progression
Bita Badiei's career trajectory showcases significant advancement within the pharmaceutical industry. She progressed from a laboratory analyst in Quality at Baxter Healthcare Corporation to her current role as Executive Director in the Regulatory Affairs Group at Kite Pharma. This progression highlights her expertise and commitment to the field.